Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.86B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.82B |
| 3 |
Mercado Libre
MELI
|
+$1.59B |
| 4 |
TSMC
TSM
|
+$1.34B |
| 5 |
Coupang
CPNG
|
+$1.27B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$2.61B |
| 2 |
EPAM Systems
EPAM
|
+$1.48B |
| 3 |
Twilio
TWLO
|
+$1.35B |
| 4 |
Apple
AAPL
|
+$1.24B |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$1.18B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.54% |
| 2 | Healthcare | 9.8% |
| 3 | Financials | 9.16% |
| 4 | Consumer Discretionary | 8.42% |
| 5 | Communication Services | 6.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3376
PIMCO Investment Grade Corporate Bond Index Exchange-Traded Fund
CORP
$1.58B
| $6.4M | ﹤0.01% |
61,452
-13,453
| -18% | -$1.44M |
|
3377
Fresenius Medical Care
FMS
$12.6B
| $6.4M | ﹤0.01% |
189,975
-143,224
| -43% | -$4.71M |
|
3378
Invesco MSCI Sustainable Future ETF
ERTH
$138M
| $6.38M | ﹤0.01% |
103,798
+4,140
| +4% | +$250K |
|
3379
Invesco Municipal Trust
VKQ
$551M
| $6.37M | ﹤0.01% |
553,062
-539
| -0.1% | -$6.44K |
|
3380
Atomera
ATOM
$219M
| $6.36M | ﹤0.01% |
486,594
+204,020
| +72% | +$3.05M |
|
3381
4D Molecular Therapeutics
FDMT
$600M
| $6.35M | ﹤0.01% |
420,036
-14,042
| -3% | -$221K |
|
3382
HCI Group
HCI
$2.3B
| $6.35M | ﹤0.01% |
93,110
+43,399
| +87% | +$2.97M |
|
3383
HNI Corp
HNI
$3.52B
| $6.35M | ﹤0.01% |
171,323
-22,658
| -12% | -$914K |
|
3384
Verrica Pharmaceuticals
VRCA
$85.9M
| $6.34M | ﹤0.01% |
78,171
-12,928
| -14% | -$1.07M |
|
3385
Preferred Bank
PFBC
$1.27B
| $6.34M | ﹤0.01% |
85,549
-1,351
| -2% | -$105K |
|
|
INBX
3386
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $6.34M | ﹤0.01% |
284,419
+228,052
| +405% | +$5.82M |
|
|
FRG
3387
DELISTED
Franchise Group, Inc.
FRG
| $6.33M | ﹤0.01% |
152,851
+29,271
| +24% | +$1.36M |
|
3388
Valaris
VAL
$5.98B
| $6.33M | ﹤0.01% |
121,802
+95,686
| +366% | +$4.14M |
|
|
EVRI
3389
DELISTED
Everi Holdings
EVRI
| $6.32M | ﹤0.01% |
300,849
-52,446
| -15% | -$1.12M |
|
|
VXRT
3390
DELISTED
Vaxart
VXRT
| $6.31M | ﹤0.01% |
1,252,809
+1,058,992
| +546% | +$5.36M |
|
|
VCSA
3391
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
| $6.31M | ﹤0.01% |
38,165
+38,115
| +76,230% | +$5.57M |
|
3392
Logitech
LOGI
$14.8B
| $6.3M | ﹤0.01% |
85,332
-3,521
| -4% | -$273K |
|
3393
Xtrackers Russell US Multifactor ETF
DEUS
$307M
| $6.29M | ﹤0.01% |
138,010
-30,851
| -18% | -$1.4M |
|
3394
Hamilton Lane
HLNE
$5.77B
| $6.28M | ﹤0.01% |
81,226
-17,241
| -18% | -$1.44M |
|
3395
Addus HomeCare
ADUS
$2.17B
| $6.27M | ﹤0.01% |
67,225
+3,676
| +6% | +$296K |
|
3396
National Bank Holdings
NBHC
$1.94B
| $6.27M | ﹤0.01% |
155,572
+3,627
| +2% | +$161K |
|
3397
Invesco Russell 1000 Equal Weight ETF
EQAL
$850M
| $6.26M | ﹤0.01% |
134,739
+3,273
| +2% | +$148K |
|
|
CUTR
3398
DELISTED
Cutera, Inc.
CUTR
| $6.26M | ﹤0.01% |
90,793
-13,910
| -13% | -$563K |
|
3399
CEVA Inc
CEVA
$901M
| $6.26M | ﹤0.01% |
154,013
-5,116
| -3% | -$199K |
|
3400
Home BancShares
HOMB
$6.3B
| $6.25M | ﹤0.01% |
276,560
+57,427
| +26% | +$1.36M |
|
Similar funds
Morgan Stanley's Q1 2022 Portfolio in Review
As of Q1 2022, Morgan Stanley held 8,434 positions worth $741B, down 8.4% from $810B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Morgan Stanley's Q1 2022 filing shows 238 new, 3,520 increased, 3,560 reduced and 255 closed positions. Its largest new stake was Shell: 4,762,346 shares worth $262M. The largest sale was Mastercard, an estimated $2.61B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.
- Morgan Stanley's largest Q1 2022 buy was Shell: 4,762,346 shares worth $262M.
- Morgan Stanley added most to iShares 20+ Year Treasury Bond ETF in Q1 2022, an estimated $1.86B increase.
- Morgan Stanley's biggest Q1 2022 reduction was Mastercard, cutting an estimated $2.61B.
- Morgan Stanley fully exited Nuance Communications, Inc. in Q1 2022, selling an estimated $961M.
- Morgan Stanley's ten largest holdings make up 15% of its $741B portfolio in Q1 2022.
- Morgan Stanley opened 238 new positions and closed 255 in Q1 2022.
- Morgan Stanley's portfolio value fell 8.4% quarter-over-quarter to $741B.
Based on Morgan Stanley's 13F filing for Q1 2022, filed 13 May 2022.